Philip Morris International's U.S. Affiliate Swedish Match USA Receives FDA's Marketing Granted Orders To Advertise 11 ZYN ULTRA Moist Oral Nicotine Pouch Products

Philip Morris International Inc. (NYSE:PM) today announces that the U.S. Food and Drug Administration (FDA) issued Marketing Granted Orders to PMI’s U.S. affiliate, Swedish Match USA, Inc., authorizing the marketing of 11 ZYN ULTRA moist oral nicotine pouch products, including all 9mg variants and one 11mg variant. Additional 11mg variants remain under scientific review.

Today’s action further enhances PMI’s leadership role in the smoke-free category.